Vitaly Balan Selected Research

Vitaly Balan Research Topics

Disease

18	Neoplasms (Cancer) 01/2021 - 06/2006
7	Neoplasm Metastasis (Metastasis) 04/2014 - 08/2007
5	Breast Neoplasms (Breast Cancer) 04/2014 - 12/2008
4	Prostatic Neoplasms (Prostate Cancer) 04/2013 - 04/2009
2	Pathologic Processes 08/2015 - 01/2012
1	Fibrosis (Cirrhosis) 12/2022
1	Oropharyngeal Neoplasms 11/2021
1	Inflammation (Inflammations) 01/2016
1	Thyroid Neoplasms (Thyroid Cancer) 10/2014
1	Heart Failure 04/2014
1	Immune System Diseases (Immune Disorders) 04/2014
1	Noninfiltrating Intraductal Carcinoma (DCIS) 05/2013
1	Carcinoma (Carcinomatosis) 01/2012
1	Retinoblastoma (Glioblastoma, Retinal) 04/2009

Drug/Important Bio-Agent (IBA)

14	Galectin 3 (LGALS3)IBA 12/2022 - 12/2008
6	Proteins (Proteins, Gene)FDA Link 04/2014 - 12/2008
4	Metalloproteases (Metalloproteinases)IBA 12/2022 - 12/2010
3	Biomarkers (Surrogate Marker)IBA 12/2022 - 04/2014
3	Galectins (Galectin)IBA 04/2014 - 04/2010
3	Matrix Metalloproteinases (MMPs)IBA 05/2013 - 12/2008
2	Peptides (Polypeptides)IBA 12/2022 - 12/2010
2	CateninsIBA 04/2014 - 04/2013
2	Glucose-6-Phosphate Isomerase (Phosphoglucose Isomerase)IBA 04/2014 - 02/2013
2	Mitogen-Activated Protein KinasesIBA 05/2013 - 02/2013
2	Carrier Proteins (Binding Protein)IBA 04/2013 - 04/2009
2	saccharide-binding proteinsIBA 02/2012 - 12/2008
1	CollagenIBA 12/2022
1	CytokinesIBA 11/2021
1	Immune Checkpoint InhibitorsIBA 01/2021
1	RNA Precursors (Precursor, mRNA)IBA 08/2015
1	Conditioned Culture MediaIBA 05/2013
1	GelatinIBA 05/2013
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 05/2013
1	Complex MixturesIBA 05/2013
1	Nuclear Pore Complex Proteins (Nucleoporins)IBA 04/2013
1	nuclear pore complex protein 98IBA 04/2013
1	Serine Proteases (Serine Protease)IBA 04/2013
1	Chymotrypsin FDA Link 04/2013
1	EnzymesIBA 04/2013
1	Prostate-Specific Antigen (Semenogelase)IBA 04/2013
1	Trastuzumab (Herceptin)FDA Link 02/2013
1	Glycoproteins (Glycoprotein)IBA 02/2012
1	CarbohydratesIBA 02/2012
1	GlycoconjugatesIBA 01/2012
1	Tumor Biomarkers (Tumor Markers)IBA 04/2010
1	beta-galactosideIBA 04/2009
1	Cyclin D1IBA 04/2009
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 04/2009
1	Tumor Suppressor Proteins (Proteins, Tumor Suppressor)IBA 04/2009
1	Small Interfering RNA (siRNA)IBA 04/2009
1	Cyclin EIBA 04/2009
1	Indicators and Reagents (Reagents)IBA 08/2007
1	raf KinasesIBA 08/2007
1	14-3-3 Proteins (14-3-3 Protein)IBA 06/2006

Therapy/Procedure

5	Therapeutics 01/2020 - 02/2013
2	Immunotherapy 01/2020 - 01/2020